protocolSection identificationModule nctId: NCT06261957, orgStudyIdInfo id: 220735, secondaryIdInfos id: 2023-509001-76-00, type: OTHER, domain: EU CT Number, briefTitle: A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-19, primaryCompletionDateStruct date: 2025-04-25, completionDateStruct date: 2025-04-25, studyFirstPostDateStruct date: 2024-02-15, lastUpdatePostDateStruct date: 2024-02-15, sponsorCollaboratorsModule leadSponsor name: GlaxoSmithKline, class: INDUSTRY, descriptionModule briefSummary: The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged 12 years and above with asthma., conditionsModule conditions: Asthma, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 420, type: ESTIMATED, armsInterventionsModule interventions name: Salbutamol HFA-134a, interventions name: Salbutamol HFA-152a, outcomesModule primaryOutcomes measure: Number of participants with Adverse Events (AEs), secondaryOutcomes measure: Number of participants with Serious Adverse Events (SAEs), secondaryOutcomes measure: Absolute Values of Minimum serum potassium (milliequivalents per litre (mEq/L), secondaryOutcomes measure: Absolute values of serum potassium (milligrams per decilitre), secondaryOutcomes measure: Change from baseline in serum potassium (milligrams per decilitre), secondaryOutcomes measure: Absolute value of haematology parameter: Platelet count (cells per microliter), secondaryOutcomes measure: Absolute value of haematology parameter: Red Blood Cell Count (RBC) (million cells per microliter), secondaryOutcomes measure: Absolute value of haematology parameter: Mean Corpuscle Volume (MCV) (Femtoliters), secondaryOutcomes measure: Absolute value of haematology parameter: Mean Corpuscle haemoglobin (MCH) (Picograms), secondaryOutcomes measure: Absolute values of haematology parameters: Reticulocytes (Percentage of reticulocytes), secondaryOutcomes measure: Absolute values of haematology parameters: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils (giga cells per litre), secondaryOutcomes measure: Absolute values of haematology parameters: haemoglobin (Hgb) (grams per decilitre), secondaryOutcomes measure: Absolute values of haematology parameters: haematocrit (Proportion of red blood cells in blood), secondaryOutcomes measure: Absolute values of Clinical Chemistry parameters: Glucose (non-fasting), Blood Urea Nitrogen (BUN), Creatinine, Sodium, Potassium, Calcium, Direct Bilirubin and Total Bilirubin (milligrams per decilitre), secondaryOutcomes measure: Absolute values of Aspartate aminotransferase/serum glutamic-oxaloacetic transaminase,Alanine aminotransferase/serum glutamic-pyruvic transaminase, Alanine aminotransferase,Creatine phosphokinase (International Units per litre), secondaryOutcomes measure: Absolute value of routine urinalysis: potential of hydrogen (pH), secondaryOutcomes measure: Number of participants with abnormal urinalysis dipstick results: glucose, protein, blood, ketones, bilirubin, urobilinogen, nitrite, leukocyte esterase, secondaryOutcomes measure: Change from baseline in haematology parameter: Platelet count (cells per microliter), secondaryOutcomes measure: Change from baseline in haematology parameter: Red Blood Cell Count (RBC) (million cells per microliter), secondaryOutcomes measure: Change from baseline in haematology parameter: Mean Corpuscle Volume (MCV) (Femtoliters), secondaryOutcomes measure: Change from baseline in haematology parameter: Mean Corpuscle haemoglobin (MCH) (Picograms), secondaryOutcomes measure: Change from baseline in haematology parameters: Reticulocytes (Percentage of reticulocytes), secondaryOutcomes measure: Change from baseline in haematology parameters: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils (giga cells per litre), secondaryOutcomes measure: Change from baseline in haematology parameters: haemoglobin (Hgb) (grams per decilitre), secondaryOutcomes measure: Change from baseline in haematology parameters: haematocrit (Proportion of red blood cells in blood), secondaryOutcomes measure: Change from baseline in Clinical Chemistry parameters: Glucose (non-fasting), Blood Urea Nitrogen (BUN), Creatinine, Sodium, Potassium, Calcium, Direct Bilirubin and Total Bilirubin (milligrams per decilitre), secondaryOutcomes measure: Change from baseline in Aspartate aminotransferase/ serum glutamic-oxaloacetic transaminase,Alanine aminotransferase/serum glutamic-pyruvic transaminase, Alanine aminotransferase,Creatine phosphokinase (International Units per litre), secondaryOutcomes measure: Change from baseline in routine urinalysis: pH, secondaryOutcomes measure: Absolute values for vital signs: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) [millimeters of mercury (mm Hg), secondaryOutcomes measure: Absolute values for vital signs: pulse rate [beats per min (bpm), secondaryOutcomes measure: Change from baseline in vital signs: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) [millimeters of mercury (mm Hg), secondaryOutcomes measure: Change from baseline in vital signs: pulse rate [beats per min (bpm), secondaryOutcomes measure: Absolute values for 12 Lead ECGs in QTc (milliseconds), secondaryOutcomes measure: Absolute values for heart rate [beats per min (bpm), secondaryOutcomes measure: Change from baseline for 12 Lead ECGs in QTc (milliseconds), secondaryOutcomes measure: Change from baseline for heart rate [beats per min (bpm), eligibilityModule sex: ALL, minimumAge: 12 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: GSK Investigational Site, city: Aventura, state: Florida, zip: 33180, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Jaime Landman, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 25.95648, lon: -80.13921, locations facility: GSK Investigational Site, city: Clearwater, state: Florida, zip: 33756, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Miguel E Trevino, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 27.96585, lon: -82.8001, locations facility: GSK Investigational Site, city: Edgewater, state: Florida, zip: 32132, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Andrew C Feldman, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 28.98888, lon: -80.90228, locations facility: GSK Investigational Site, city: Miami, state: Florida, zip: 33155, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Eduardo Martinez, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 25.77427, lon: -80.19366, locations facility: GSK Investigational Site, city: Winter Park, state: Florida, zip: 32789, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Akinyemi Ajayi, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 28.6, lon: -81.33924, locations facility: GSK Investigational Site, city: Rincon, state: Georgia, zip: 31326, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Maria Mascolo, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 32.29603, lon: -81.23539, locations facility: GSK Investigational Site, city: Louisville, state: Kentucky, zip: 40217, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: James Wesley Sublett, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 38.25424, lon: -85.75941, locations facility: GSK Investigational Site, city: Owensboro, state: Kentucky, zip: 42301, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Lee S Clore, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 37.77422, lon: -87.11333, locations facility: GSK Investigational Site, city: Minneapolis, state: Minnesota, zip: 55402, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Gary D Berman, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 44.97997, lon: -93.26384, locations facility: GSK Investigational Site, city: Olive Branch, state: Mississippi, zip: 38654, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Randall T. Huling, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.96176, lon: -89.82953, locations facility: GSK Investigational Site, city: Columbia, state: Missouri, zip: 65203, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Mark L Vandewalker, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 38.95171, lon: -92.33407, locations facility: GSK Investigational Site, city: Jersey City, state: New Jersey, zip: 07306, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Asisat Ope, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.72816, lon: -74.07764, locations facility: GSK Investigational Site, city: Riverdale, state: New Jersey, zip: 07457, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Jeffrey Weiss, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.99399, lon: -74.30348, locations facility: GSK Investigational Site, city: Brooklyn, state: New York, zip: 11220, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Ramsey Joudeh, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.6501, lon: -73.94958, locations facility: GSK Investigational Site, city: Asheville, state: North Carolina, zip: 28803, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: David Cypcar, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 35.60095, lon: -82.55402, locations facility: GSK Investigational Site, city: Cincinnati, state: Ohio, zip: 45231, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: David I Bernstein, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.12713, lon: -84.51435, locations facility: GSK Investigational Site, city: Dublin, state: Ohio, zip: 43016, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Roy Carl St. John, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.09923, lon: -83.11408, locations facility: GSK Investigational Site, city: Medford, state: Oregon, zip: 97504, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Sarah Smiley, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 42.32652, lon: -122.87559, locations facility: GSK Investigational Site, city: DuBois, state: Pennsylvania, zip: 15801, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Sandeep Bansal, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.11923, lon: -78.76003, locations facility: GSK Investigational Site, city: Philadelphia, state: Pennsylvania, zip: 19107, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: David A Wheeler, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.95233, lon: -75.16379, locations facility: GSK Investigational Site, city: Pittsburgh, state: Pennsylvania, zip: 15241, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Michael J. Palumbo, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.44062, lon: -79.99589, locations facility: GSK Investigational Site, city: Greenville, state: South Carolina, zip: 29615, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Luis Ignacio De La Cruz, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.85262, lon: -82.39401, locations facility: GSK Investigational Site, city: Rock Hill, state: South Carolina, zip: 29732, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Michael Denenberg, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.92487, lon: -81.02508, locations facility: GSK Investigational Site, city: Spartanburg, state: South Carolina, zip: 29303, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Charles M. Fogarty, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.94957, lon: -81.93205, locations facility: GSK Investigational Site, city: Union, state: South Carolina, zip: 29379, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Joseph A Boscia III, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 34.71541, lon: -81.62371, locations facility: GSK Investigational Site, city: Burleson, state: Texas, zip: 76028, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Tiffany Baird, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 32.54208, lon: -97.32085, locations facility: GSK Investigational Site, city: Tomball, state: Texas, zip: 77375, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Mustafa Naeem, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.09716, lon: -95.61605, locations facility: GSK Investigational Site, city: Waco, state: Texas, zip: 76712, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Niran J. Amar, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 31.54933, lon: -97.14667, locations facility: GSK Investigational Site, city: Bellingham, state: Washington, zip: 98225, country: United States, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: David Elkayam, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 48.75955, lon: -122.48822, locations facility: GSK Investigational Site, city: Caba, state: Buenos Aires, zip: C1425BEN, country: Argentina, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Anahi Yanez, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: -34.61315, lon: -58.37723, locations facility: GSK Investigational Site, city: Ciudad de Buenos Aires, zip: C1425AZE, country: Argentina, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Nicolas Itcovici, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: -34.61315, lon: -58.37723, locations facility: GSK Investigational Site, city: Mendoza, zip: M5500CCG, country: Argentina, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Pedro Carlos Elias, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: -32.89084, lon: -68.82717, locations facility: GSK Investigational Site, city: Ajax, state: Ontario, zip: L1S 2J5, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: George Philteos, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.85012, lon: -79.03288, locations facility: GSK Investigational Site, city: Brampton, state: Ontario, zip: L6T 0G1, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Naresh K. Aggarwal, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.68341, lon: -79.76633, locations facility: GSK Investigational Site, city: Ottawa, state: Ontario, zip: K1H 1E4, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: William Yang, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.41117, lon: -75.69812, locations facility: GSK Investigational Site, city: Toronto, state: Ontario, zip: M9V 4B4, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Anil Gupta, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.70011, lon: -79.4163, locations facility: GSK Investigational Site, city: Windsor, state: Ontario, zip: N8X 2G1, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Joel Liem, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 42.30008, lon: -83.01654, locations facility: GSK Investigational Site, city: Quebec, zip: G1V 4W2, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Remi Gagnon, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 46.81228, lon: -71.21454, locations facility: GSK Investigational Site, city: Quebec, zip: G1W 4R4, country: Canada, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Catherine Vaillancourt, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 46.81228, lon: -71.21454, locations facility: GSK Investigational Site, city: Amiens Cedex 1, zip: 80054, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Sandrine Soriot-Thomas, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 49.9, lon: 2.3, locations facility: GSK Investigational Site, city: Argenteuil, zip: 95100, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Vincent Ioos, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 48.95, lon: 2.25, locations facility: GSK Investigational Site, city: Brest cedex, zip: 29609, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Pierrick Cros, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 48.3903, lon: -4.48628, locations facility: GSK Investigational Site, city: Cannes Cedex, zip: 06614, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Fabien Rolland, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.55135, lon: 7.01275, locations facility: GSK Investigational Site, city: Créteil Cedex, zip: 94010, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Ralph Epaud, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 48.78333, lon: 2.46667, locations facility: GSK Investigational Site, city: Libourne Cedex, zip: 33505, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Laurent Portel, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 44.91667, lon: -0.23333, locations facility: GSK Investigational Site, city: Lille, zip: 59000, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Caroline Thumerelle, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 50.63297, lon: 3.05858, locations facility: GSK Investigational Site, city: Poitiers cedex, zip: 86021, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Etienne-Marie Jutant, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 46.58333, lon: 0.33333, locations facility: GSK Investigational Site, city: Pontoise, zip: 95303, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Jean-François Boitiaux, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 49.05, lon: 2.1, locations facility: GSK Investigational Site, city: Strasbourg Cedex, zip: 67091, country: France, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Naji Khayath, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 48.58392, lon: 7.74553, locations facility: GSK Investigational Site, city: Larissa, state: Thessaly, zip: 41110, country: Greece, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Konstantinos Gourgoulianis, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.63689, lon: 22.41761, locations facility: GSK Investigational Site, city: Alexandroupolis, zip: 68100, country: Greece, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Paschalis Steiropoulos, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.84995, lon: 25.87644, locations facility: GSK Investigational Site, city: Athina, zip: 11527, country: Greece, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Paraskevi Xepapadaki, role: PRINCIPAL_INVESTIGATOR, locations facility: GSK Investigational Site, city: Heraklion, Crete, zip: 71500, country: Greece, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Emmanouil Paraskakis, role: PRINCIPAL_INVESTIGATOR, locations facility: GSK Investigational Site, city: Thessaloniki, zip: 57010, country: Greece, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Konstantinos Porpodis, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.64361, lon: 22.93086, locations facility: GSK Investigational Site, city: Monserrato, state: Cagliari, zip: 09042, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Stefano Del Giacco, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.25642, lon: 9.1444, locations facility: GSK Investigational Site, city: Napoli, state: Campania, zip: 80131, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Giuseppe Spadaro, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.85216, lon: 14.26811, locations facility: GSK Investigational Site, city: Roma, state: Lazio, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Paolo Palange, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.89193, lon: 12.51133, locations facility: GSK Investigational Site, city: Milano, state: Lombardia, zip: 20162, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Paolo Tarsia, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.46427, lon: 9.18951, locations facility: GSK Investigational Site, city: Varese, state: Lombardia, zip: 21100, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Antonio Spanevello, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.82058, lon: 8.82511, locations facility: GSK Investigational Site, city: Foggia, state: Puglia, zip: 71100, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Donato Lacedonia, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.45845, lon: 15.55188, locations facility: GSK Investigational Site, city: Padova, state: Veneto, zip: 35128, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Andrea Vianello, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.40797, lon: 11.88586, locations facility: GSK Investigational Site, city: Verona, state: Veneto, zip: 37134, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Claudio Micheletto, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.4299, lon: 10.98444, locations facility: GSK Investigational Site, city: Firenze, zip: 50134, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Federico Lavorini, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 43.77925, lon: 11.24626, locations facility: GSK Investigational Site, city: Torino, zip: 10128, country: Italy, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Luisa Brussino, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 45.07049, lon: 7.68682, locations facility: GSK Investigational Site, city: Ciudad de Panama, zip: 7099, country: Panama, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Reynaldo Chandler, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 8.9936, lon: -79.51973, locations facility: GSK Investigational Site, city: Panama, zip: 1001, country: Panama, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Bruno Hammerschlag, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 8.9936, lon: -79.51973, locations facility: GSK Investigational Site, city: Panama, zip: 7002, country: Panama, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Lorena Noriega, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 8.9936, lon: -79.51973, locations facility: GSK Investigational Site, city: Panama, country: Panama, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Yaricelys Bravo, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 8.9936, lon: -79.51973, locations facility: GSK Investigational Site, city: Bialystok, zip: 15-010, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Piotr Siergiejko, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 53.13333, lon: 23.16433, locations facility: GSK Investigational Site, city: Bielsko-Biala, zip: 43-300, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Marta Frejowska-Reniecka, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 49.82245, lon: 19.04686, locations facility: GSK Investigational Site, city: Elblag, zip: 82-300, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Marek Mital, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 54.1522, lon: 19.40884, locations facility: GSK Investigational Site, city: Katowice, zip: 40-083, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Szymon Placzek, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 50.25841, lon: 19.02754, locations facility: GSK Investigational Site, city: Katowice, zip: 40-600, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Jakub Kwiatkowski, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 50.25841, lon: 19.02754, locations facility: GSK Investigational Site, city: Ostrowiec Swietokrzyski, zip: 27-400, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Anna Olech-Cudzik, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 50.92936, lon: 21.38525, locations facility: GSK Investigational Site, city: Plock, zip: 09-407, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Maria Wozniak, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 52.54682, lon: 19.70638, locations facility: GSK Investigational Site, city: Tarnow, zip: 33-100, country: Poland, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Bernadetta Majorek-Olechowska, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 50.01381, lon: 20.98698, locations facility: GSK Investigational Site, city: Soham, state: Cambridgeshire, zip: CB7 5JD, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Anthony Gunstone, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 52.33543, lon: 0.33654, locations facility: GSK Investigational Site, city: Rhyl, state: Denbighshire, zip: LL18 4HZ, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Selena Harris, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 53.31929, lon: -3.49228, locations facility: GSK Investigational Site, city: Ashton-under-Lyne, state: Greater Manchester, zip: OL6 6HD, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Omair Razzaq, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 53.48876, lon: -2.0989, locations facility: GSK Investigational Site, city: Corby, state: Northamptonshire, zip: NN17 2UR, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Amardeep Heer, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 52.49637, lon: -0.68939, locations facility: GSK Investigational Site, city: Guisborough, state: South Tees, zip: TS14 7DJ, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Teik Goh, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 54.53478, lon: -1.05606, locations facility: GSK Investigational Site, city: Bebington, zip: CH63 9JP, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Athanasios Simopoulos, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 53.35, lon: -3.01667, locations facility: GSK Investigational Site, city: Hounslow, zip: TW3 3EL, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Ivor Singh, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 51.46839, lon: -0.36092, locations facility: GSK Investigational Site, city: Uttoxeter, zip: ST14 5JX, country: United Kingdom, contacts name: US GSK Clinical Trials Call Center, role: CONTACT, phone: 877-379-3718, email: GSKClinicalSupportHD@gsk.com, contacts name: EU GSK Clinical Trials Call Centre, role: CONTACT, phone: +44 (0) 20 8990 4466, email: GSKClinicalSupportHD@gsk.com, contacts name: Satveer Poonian, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 52.89838, lon: -1.86488, hasResults: False